ANKRD60 Inhibitors are a specialized class of chemical compounds designed to target and inhibit the function of the ANKRD60 (Ankyrin Repeat Domain-containing Protein 60) protein, a member of the ankyrin repeat family. These proteins are characterized by their ankyrin repeat domains, which are typically involved in facilitating protein-protein interactions, crucial for various cellular processes such as signal transduction, structural organization, and cellular response mechanisms. ANKRD60 Inhibitors work by binding to the ankyrin repeat domains of the ANKRD60 protein, thereby obstructing its ability to interact with other proteins. The binding of these inhibitors can cause conformational changes in ANKRD60 or simply block the interaction interface, effectively preventing the protein from participating in its usual biological functions. The design of these inhibitors is usually highly specific, taking into account the unique structural features of the ANKRD60 protein to ensure that the inhibitor binds with high affinity and specificity.
The chemical properties of ANKRD60 Inhibitors, such as their molecular weight, solubility, and structural configuration, are critical factors that influence their efficacy in inhibiting the ANKRD60 protein. These inhibitors often contain functional groups that enhance their binding to the ankyrin repeat domains, such as hydrophobic moieties that interact with non-polar regions of the protein or polar and charged groups that form hydrogen bonds or ionic interactions with key residues. The stability of these inhibitors in the cellular environment is also an important consideration, as it ensures that they remain effective over the necessary duration. Additionally, the kinetics of inhibitor binding, including the rates of association and dissociation with the ANKRD60 protein, are crucial in determining the overall impact of the inhibitor on protein function. By inhibiting ANKRD60, these compounds can provide insights into the protein's role in cellular mechanisms, helping to elucidate the broader biological processes in which ANKRD60 is involved. Understanding these interactions at the molecular level is essential for comprehending how ANKRD60 contributes to the regulation of various cellular activities.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A inhibits histone deacetylases, leading to chromatin remodeling and potential suppression of ANKRD60 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound inhibits DNA methyltransferase, which may result in reduced methylation and decreased ANKRD60 expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A binds to DNA and prevents transcription factor binding, possibly downregulating ANKRD60 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting RNA polymerase and potentially decreasing ANKRD60 mRNA synthesis. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor that may lead to hypomethylation and silencing of the ANKRD60 gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Decitabine incorporates into DNA and inhibits methylation, which could reduce ANKRD60 gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor, potentially altering chromatin and decreasing ANKRD60 expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium butyrate acts as a histone deacetylase inhibitor, which may result in downregulation of ANKRD60. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
Entinostat selectively inhibits class I histone deacetylases, potentially suppressing ANKRD60 gene expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Alpha-amanitin inhibits RNA polymerase II, which may reduce transcription of the ANKRD60 gene. | ||||||